title: Characterization of a novel human anti-HIV-1 gp41 IgM monoclonal antibody designated clone 37.
abstract: Human monoclonal antibodies (HuMAbs) demonstrate great potential for passive immunotherapy against HIV-1. The gp41 transmembrane envelope glycoprotein of HIV has an important role in the pathogenicity of AIDS and importantly displays considerably less hypervariability than the gp120 surface envelope HIV glycoprotein, which makes it particularly a better candidate for the development of passive and active immunotherapies. The general aim of this study was to develop HuMAbs to HIV surface glycoproteins and particularly gp41. Peripheral blood mononuclear cells (PBMCs) were isolated from an HIV-seropositive long-term nondisease progressing patient. B-cells from this individual were then immortalized by Epstein-Barr virus (EBV) transformation, and antibody production was stabilized by fusion of transformed cells with a heteromyeloma. Subsets of the human heterohybridomas so generated were analyzed by ELISA. The hybridoma with the highest binding by immunoassay against gp160 was further analyzed. This hybridoma, designated as clone 37 (C37), was determined to be an IgM Kappa antibody and overlapping peptides of HIV envelope proteins (derived from the MN tissue culture line adapted HIV isolate) were used to map the specific binding domain of this HuMAb. Overlapping peptides designated 2026 (SWSNKSLDDIWNN, AA614-626), and 2027 (DDIWNNMTWMQWEREIDNYT, AA621-640) within the HIV-1 gp41 transmembrane glycoprotein were demonstrated to bind to C37 indicating that the specific binding domain for the antibody was DDIWNN. High affinity binding of C37 by ELISA to recombinant gp41 was demonstrated as well. Few IgM HuMAbs against HIV have been generated and characterized. Theoretically, because of the pentameric binding nature of IgM antibodies as well as their very efficient ability to activate complement, such reagents could have potential as anti-HIV agents.
authors.affiliation: Department of Medical Microbiology and Immunology, University of South Florida, Tampa, Florida 33612, USA.
authors.forename: Chuanhai
authors.initials: C
authors.lastname: Cao
authors.forename: Yun
authors.initials: Y
authors.lastname: Bai
authors.forename: Mary Jolene
authors.initials: MJ
authors.lastname: Holloway
authors.forename: Rebecca L
authors.initials: RL
authors.lastname: Edgeworth
authors.forename: Eugene A
authors.initials: EA
authors.lastname: Jackson
authors.forename: Joseph
authors.initials: J
authors.lastname: Cotropia
authors.forename: Kenneth E
authors.initials: KE
authors.lastname: Ugen
mesh_terms: D000595:Amino Acid Sequence; D000911:Antibodies, Monoclonal / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D015153:Blotting, Western; D002461:Cell Line, Transformed; D004797:Enzyme-Linked Immunosorbent Assay; D015700:HIV Envelope Protein gp41 / Q000737:chemistry / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology*; D007075:Immunoglobulin M / Q000276:immunology*; D008969:Molecular Sequence Data
chemical_list: D000911:Antibodies, Monoclonal; D015700:HIV Envelope Protein gp41; D007075:Immunoglobulin M